Nellson Nutraceutical, LLC
2 BDCs lend $14M to Nellson Nutraceutical, LLC at spreads of 475 to 575 bps over SOFR, maturing Apr 2031; marks agree within 3.0 points.
A full-service contract manufacturer of nutritional bars and functional powders in North America, providing custom formulation, blending, extrusion and packaging for nutrition and supplement brands (products such as protein bars, nutrition bars and powdered supplements).
Company profile. Written by an AI model from public web sources. No one has checked it against those sources, and it is not taken from the company's or the lender's SEC filing. It is distinct from the SEC Schedule-of-Investments pricing data below. AI-generated analysis. Not investment advice. May contain errors.
Figures as of each lender’s latest reported period, 2026-06-30 to 2026-09-30; filed 2026-08-05 to 2026-11-03.
Lenders
Nellson Nutraceutical, LLC is held by 2 BDC lenders in our parsed SEC filings: NCDL, OCSL.
Cross-lender loan pricing
Each row is one debt tranche at the BDC’s most recent filing that holds this borrower, widest spread first. Mark is the position’s fair value per 100 of par (100 = par). Spread is shown in basis points over the benchmark in the Rate column, normalized from each filing’s as-reported units — rows quoting different benchmarks are still not directly comparable. Compare like-for-like: a second-lien tranche, a different vintage, or an older filing should price wider even when the credit view is identical — check the Seniority and As of columns before reading a gap as disagreement. Source: SEC EDGAR (public). Lenders whose newest filing no longer names this borrower are listed separately under “Exited” below.
Marks are per 100 of par, current lenders only. Rows tagged “unfunded” or “n/m, not a price” are listed but left out of every average, range and comparison; a mark tagged “above 105, as filed” is shown but left out too.
Mixed reporting periods: these rows are as of 2026-06-30 and 2026-09-30. Each lender reports on its own schedule, so a mark from a later quarter can differ for reasons other than a different view of the credit — compare rows with the same As-of date first.
| BDC | Seniority | Rate | Cash spread (bps) | Mark | Fair value | Maturity | As of |
|---|---|---|---|---|---|---|---|
| NCDL | First lien | SOFR | 575 | unfunded | — | Apr 2031 | 2026-09-30filed 2026-11-03 |
| NCDL | First lien | SOFR | 575 | 100.1 | $919K | Apr 2031 | 2026-09-30filed 2026-11-03 |
| OCSL | First lien | SOFR | 575 | 98.8 | $3M | Apr 2031 | 2026-06-30filed 2026-08-05 |
| OCSL | First lien | SOFR | 575 | 98.8 | $9M | Apr 2031 | 2026-06-30filed 2026-08-05 |
| OCSL | First lien | SOFR | 475 | 97.1 | $761K | Apr 2031 | 2026-06-30filed 2026-08-05 |
Marks reflect each BDC’s own fair-value estimates as reported to the SEC, not traded prices. Private-credit loans are predominantly Level 3 under ASC 820 — valued from unobservable inputs and determined in good faith under the oversight of each BDC’s board (often by the adviser as valuation designee), so figures are estimates as of the period end each filing reports, not its filing date, and are not directly comparable across managers. Informational only; not investment advice or a valuation.
Exited
Exited or inactive lenders: last-filed positions, not current. Excluded from every count and figure above.
Reading this table
When two business development companies lend to the same borrower, comparing how each marks the loan is a starting question, not a verdict. In plain English: a wider spread (e.g. SOFR + 575 vs SOFR + 525 bps) or a lower mark (e.g. 96 vs 100 cents on the dollar) can mean that lender is pricing in more risk — but marks can also differ for reasons other than a credit view: a different tranche (second lien should price wider than first lien on the same company), a different vintage or entry point, an older filing date, or each manager’s own fair-value methodology. Compare like-for-like — check the Seniority and As of columns before reading a gap as disagreement. Each row is one debt position at one BDC’s most recent filing. Source: SEC EDGAR Schedule of Investments (public).
Terms in this table: SOFR (the floating benchmark most of these loans pay over); spread in basis points (bps; 100 bps is one percentage point); first lien and second lien; PIK (interest paid in more debt instead of cash); non-accrual; par (the face amount owed); and Level 3 fair value (a manager’s own estimate, not a market price). Also: mark (fair value per 100 of par, the lender's own estimate); seniority (where a position ranks for repayment); unfunded commitment (money promised but not yet drawn); basis point (one hundredth of a percentage point).
Want to read these numbers like an analyst? Free Oxford Ledge lessons: reading a BDC’s Schedule of Investments, key credit metrics, and the Five Cs of credit analysis.
Compare more borrowers: every borrower held by two or more BDCs, or start from a BDC’s full portfolio.
Other borrowers
Held by the same BDCs
Borrowers in the newest filings of two or more of the BDCs that hold this one, most shared first.
Same industry: Packaged Foods & Meats
Borrowers held by two or more BDCs under the same industry label, most holders first.
Holder counts here are the borrower index’s. Or see the borrowers held most widely across BDCs.
Ownership & deal activity
Headlines mentioning this borrower
Public headlines that name Nellson Nutraceutical, LLC, matched by company name and shown most-recent first. A mention is not an endorsement, a rating, or investment advice — verify anything material against the original source. Source: Google News.